In 2017, MobiHealthNews covered 51 devices that received clearance from the FDA. Along with a handful of diagnostic devices, disease management platforms, and novel monitors, this year boasted a few surprises from the agency, such as the approval of a direct-to-consumer genetic tests for disease risk and a purely digital intervention.
from MobiHealthNews http://ift.tt/2DA6Khe
December 22, 2017
Rose
MobiHealthNews
No comments
Related Posts:
FDA launches mobile version of drug information databaseThe FDA has launched a free mobile app version of its Drugs@FDA online database that offers consumers information on agency-approved drugs.
from MobiHealthNews https://ift.tt/2pyXy7i
… Read More
Primary care concierge platform SteadyMD lands $2.5M in fundingPrimary care concierge platform SteadyMD just announced that it secured $2.5 million in capital support from Pelion Venture Partners and others.
from MobiHealthNews https://ift.tt/2I53xHQ
… Read More
Mobile health app development costs $425,000 on average, likely continuing to riseThe average cost of development for a mobile health app from conception to launch is approximately $425,000, with nearly half of this expense outsourced to third-party app development agencies or freelancers, according to new… Read More
In-depth: Who owns telemedicine delivery — payers or providers?Just about everyone agrees in the basic vision for telemedicine: When a person gets sick, instead of jumping in the car to drive to a doctor’s office or urgent care center, they can pick up a phone or tablet instead, and get … Read More
PhysioWave's pulse wave velocity feature gets the all-clear from FDAUniversity of Stanford spin-out PhysioWave has just received FDA clearance for its pulse wave velocity (PWV) cardiovascular analyzer scale, which measures the stiffness of the vessels transporting blood from the heart to the … Read More
Subscribe to:
Post Comments (Atom)
Rose
0 comments:
Post a Comment